Page 139 - PCC07

Bibliography
Abbara A, Islam R, Clarke SA, Jeffers L, Christopoulos G, Comninos AN, Salim R, Lavery SA, Vuong TNL, Humaidan P, Kelsey TW, Trew GH, Dhillo WS. Clinical parameters of ovarian hyperstimulation syndrome following different hormonal triggers of oocyte maturation in IVF treatment. Clin Endocrinol. 2018 doi: 10.1111/cen.13569.
Altmäe S, Hovatta O, Stavreus‐Evers A, Salumets A. Genetic predictors of controlled ovarian hyperstimulation: where do we stand today? Hum Reprod Update. 2011 Nov‐Dec;17(6):813‐28. doi: 10.1093/humupd/dmr034.
Al‐Inany HG, Youssef MA, Ayeleke RO, Brown J, Lam WS, Broekmans FJ. Gonadotrophin‐releasing hormone antagonists for assisted reproductive technology. Cochrane Database Syst Rev. 2016 Apr 29;4:CD001750. doi: 10.1002/14651858.CD001750.pub4.
Asch RH, Li HP, Balmaceda JP, Weckstein LN, Stone SC. Severe ovarian hyperstimulation syndrome in assisted reproductive technology: definition of high risk groups. Hum Reprod. 1991 Nov;6(10):1395‐9.
Baart EB, Martini E, Eijkemans MJ, Van Opstal D, Beckers NG, Verhoeff A, Macklon NS, Fauser BC. Milder ovarian stimulation for in‐vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial. Hum Reprod. 2007 Apr;22(4):980‐8. Epub 2007 Jan 4.
Balen AH, Laven JSE, Tan SL, Dewailly D. Ultrasound Assessment of the Polycystic Ovary: International Consensus Definitions. Human Reproduction Update 2003; 9: 505‐514.
Balen AH, Morley LC, Misso M, Franks S, Legro RS, Wijeyaratne CN, Stener‐Victorin E, Norman RJ, Fauser BJCM, Teede H. WHO recommendations for The Management of Anovulatory Infertility in Women with Polycystic Ovary Syndrome (PCOS), Human Reproduction Update 2016; 22: 687‐708 doi: 10.1093/humupd/dmw 025.
Brewer C, Acharya S, Thake F, Tang T, Balen AH. Effect of metformin taken in the ‘fresh’ in vitro fertilization/intracytoplasmic sperm injection cycle upon subsequent frozen embryo replacement in women with polycystic ovary syndrome. Human Fertility 2010; 13: 134‐142.
Casadei L, Madrigale A, Puca F, Manicuti C, Emidi E, Piccione E, Dewailly D. The role of serum anti‐Müllerian hormone (AMH) in the hormonal diagnosis of polycystic ovary syndrome. Gynecol Endocrinol. 2013 29:545‐50.
Chang EM, Kim YS, Won HJ, Yoon TK, Lee WS. Association between sex steroids, ovarian reserve, and vitamin D levels in healthy nonobese women. J Clin Endocrinol Metab. 2014;99:2526‐32.
Chen ZJ, Shi Y, Sun Y, Zhang B, Liang X, Cao Y, Yang J, Liu J, Wei D, Weng N, Tian L, Hao C, Yang D, Zhou F, Shi J, Xu Y, Li J, Yan J, Qin Y, Zhao H, Zhang H, Legro RS. Fresh versus Frozen Embryos for Infertility in the Polycystic Ovary Syndrome. N Engl J Med. 2016; 375:523‐33
Devroey P, Polyzos NP, Blockeel C. An OHSS‐Free Clinic by segmentation of IVF treatment. Hum Reprod. 2011; 26:2593‐7.
Dewailly D, Gronier H, Poncelet E, Robin G, Leroy M, Pigny P, Duhamel A, Catteau‐Jonard S. Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries. Hum Reprod. 2011 Nov;26(11):3123‐9.
Dewailly D, Andersen CY, Balen A, Broekmans F, Dilaver N, Fanchin R, et al. The physiology and clinical utility of anti‐ Mullerian hormone in women. Hum Reprod Update 2014; 20: 804‐24.
Page 132 of 196
PRECONGRESS COURSE 07 I BARCELONA, SPAIN – 1 JULY 2018 139